![Global Amyotrophic Lateral Sclerosis Treatment Market](https://res.cloudinary.com/devmoveo/image/upload/v1706010055/skyquest/report/phpUiM9b8.jpg)
Report ID: SQMIG35J2089
Report ID:
SQMIG35J2089 |
Region:
Global |
Published Date: July, 2036
Pages:
242
|
Tables:
65 |
Figures:
75
North America had the largest market share in 2018 and is expected to maintain that position throughout the forecast period. The factors driving the market are high healthcare expenditure, favorable reimbursement policies, high demand for ALS drugs, and established healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report, approximately 16,583 cases of amyotrophic lateral sclerosis were identified in the United States in 2015.
Over the forecast period, Asia Pacific is expected to grow at the fastest rate of all regions. This region's riluzole generic manufacturers are increasing their revenue generation, particularly in India and China. Growing R&D investment in the healthcare sector, a plethora of untapped opportunities, and promising initiatives by manufacturers and governments are some of the key factors driving market growth in this region.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2089